Skip to main content
main-content

Vasculitis

ANCA-associated vasculitis

B cell therapy in ANCA-associated vasculitis: Current and emerging treatment options

In this review, the theoretical background for use of dual B cell-targeted immunotherapy in anti-neutrophil cytoplasmic antibody-associated vasculitis is presented and discussed [read more].
McClure M et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0065-x

14-08-2018 | ANCA-associated vasculitis | Review | Article

B cell therapy in ANCA-associated vasculitis: Current and emerging treatment options

McClure M et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0065-x

Unusual case of chronic recurrent multifocal osteomyelitis

The authors present a rare case of sporadic chronic recurrent multifocal osteomyelitis in which the patient eventually developed cytoplasmic anti-neutrophil cytoplasmic antibodies-associated renal vasculitis and hyperparathyroidism [read more].
Snipaitiene A et al. Pediatr Rheumatol 2018; 16: 49. doi: 10.1186/s12969-018-0267-4

27-07-2018 | Bone diseases | Case report | Article

Unusual case of chronic recurrent multifocal osteomyelitis

The authors present a rare case of sporadic chronic recurrent multifocal osteomyelitis in which the patient eventually developed cytoplasmic anti-neutrophil cytoplasmic antibodies-associated renal vasculitis and hyperparathyroidism.

Snipaitiene A et al. Pediatr Rheumatol 2018; 16: 49. doi: 10.1186/s12969-018-0267-4

The ongoing evolution of remission maintenance strategies for granulomatosis with polyangiitis

Eric J Gapud and Philip Seo summarize the key milestones in management of severe granulomatosis with polyangiitis, and evaluate the possibility of long-term reduced intensity or drug-free remission for some patients [read more].

20-07-2018 | Granulomatosis with polyangiitis | Editorial | Article

The ongoing evolution of remission maintenance strategies for granulomatosis with polyangiitis

Eric J Gapud and Philip Seo summarize the key milestones in management of severe granulomatosis with polyangiitis, and evaluate the possibility of long-term reduced intensity or drug-free remission for some patients.

Authors:
Eric J. Gapud, Philip Seo

05-07-2018 | ANCA-associated vasculitis | News

Trimethoprim–sulfamethoxazole reduces severe infections following rituximab for vasculitis

A study looking at risk factors for the development of severe infections in patients with antineutrophil cytoplasm antibody-associated vasculitis following rituximab has found that trimethoprim–sulfamethoxazole prophylaxis may be of benefit.

Source:

Ann Rheum Dis 2018; Advance online publication

03-05-2018 | ANCA-associated vasculitis | Article

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides

Terrier B et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2017-212768

25-04-2018 | ANCA-associated vasculitis | Article

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire

Robson J et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2017-212713

02-04-2018 | Granulomatosis with polyangiitis | Article

Eosinophilic granulomatosis with polyangiitis: Newer therapies

Navarro-Mendoza EP, Tobón GJ. Curr Rheumatol Rep 2018; 20: 23. doi: 10.1007/s11926-018-0736-2

21-03-2018 | Vasculitis | Review | Article

Vasculitis in Africa

Genga E, Oyoo O, Adebajo A. Curr Rheumatol Rep 2018; 20: 4. doi: 10.1007/s11926-018-0711-y

10-03-2018 | ANCA-associated vasculitis | Review | Article

Anti-neutrophil cytoplasmic antibodies and their clinical significance

Suwanchote S et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4062-x

20-02-2018 | Granulomatosis with polyangiitis | Article

Ear, nose and throat involvement in granulomatosis with polyangiitis: How it presents and how it determines disease severity and long-term outcomes

Felicetti M et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4019-0

15-12-2017 | ANCA-associated vasculitis | Article

Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis

Hinojosa-Azaola A, Jiménez-González A, Alcocer-Castillejos N. Rheumatol Int 2017. doi: 10.1007/s00296-017-3904-1

22-09-2017 | ANCA-associated vasculitis | News

Active CV risk management needed in ANCA-associated vasculitis

A meta-analysis has highlighted the cardiovascular risk faced by patients with vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies.

Source:

Rheumatology 2017: Advance online publication

09-08-2017 | ANCA-associated vasculitis | News

‘No clear evidence’ for extending azathioprine maintenance therapy in ANCA-associated vasculitis

A post-hoc analysis of combined trial data suggests that extending azathioprine maintenance therapy beyond 18 months is not necessary for preventing relapses among patients with antineutrophil cytoplasmic autoantibody-associated vasculitis.

Source:

Rheumatology 2017; Advance online publication

image credits